Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Prodia Widyahusada TbkPRWDF 70 Net Cash per Share is $0.03 as of Mar. 2026, which is 100% below its 10-year median of 6.10. GuruFocus rates PRWDF with a GF Score™ of 70/100. The stock has 2 warning signs investors should review. Among 60 Medical Diagnostics & Research companies, PT Prodia Widyahusada Tbk ranks better than 73.33% on this metric.
The historical rank and industry rank for PT Prodia Widyahusada Tbk's Net Cash per Share or its related term are showing as below:
PRWDF'
s Price-to-Net-Cash Range Over the Past 10 Years
Min: 3.75 Med: 6.1 Max: 9.23
Current: 4.2
During the past 13 years, the highest Price-to-Net-Cash Ratio of PT Prodia Widyahusada Tbk was 9.23. The lowest was 3.75. And the median was 6.10.
PRWDF's Price-to-Net-Cash is ranked better than 73.33% of 60
companies
in the Medical Diagnostics & Research industry
Industry Median: 7.96
vs PRWDF: 4.20
PT Prodia Widyahusada Tbk (OTCPK:PRWDF) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
PT Prodia Widyahusada Tbk Net Cash per Share Related Terms
PT Prodia Widyahusada Tbk Net Cash per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Prodia Widyahusada Tbk Net Cash per Share Chart
PRWDF vs TMO, DHR, IDXX: Net Cash per Share Comparison
For the Diagnostics & Research subindustry, PT Prodia Widyahusada Tbk's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Prodia Widyahusada Tbk Price-to-Net-Cash vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PT Prodia Widyahusada Tbk's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where PT Prodia Widyahusada Tbk's Price-to-Net-Cash falls into.
PT Prodia Widyahusada Tbk Net Cash per Share Calculation
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
PT Prodia Widyahusada Tbk's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Prodia Widyahusada Tbk (PRWDF) has a Net Cash per Share of $0.03 as of Mar. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on PT Prodia Widyahusada Tbk and its competitors. This is 100% below median its historical median of 6.10. Over the past decade, PT Prodia Widyahusada Tbk's Net Cash per Share has ranged from 3.75 to 9.23. According to the industry distribution chart, PT Prodia Widyahusada Tbk ranks #16 out of 60 companies in the Medical Diagnostics & Research industry, placing it in the top 26.7%.
Is PT Prodia Widyahusada Tbk's Net Cash per Share too high?
PT Prodia Widyahusada Tbk's current Net Cash per Share of $0.03 is 100% below median its 10-year median of 6.10. Over the past 10 years, this metric has ranged from a low of 3.75 to a high of 9.23. The Medical Diagnostics & Research industry median Net Cash per Share is 7.96. PT Prodia Widyahusada Tbk's value of $0.03 is 99.6% below this industry median. Based on the distribution chart, PT Prodia Widyahusada Tbk ranks #16 out of 60 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, PT Prodia Widyahusada Tbk has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does PT Prodia Widyahusada Tbk's Net Cash per Share compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, PT Prodia Widyahusada Tbk ranks #16 out of 60 companies for Net Cash per Share. This puts PT Prodia Widyahusada Tbk in the upper half of its industry. The industry median Net Cash per Share is 7.96. PT Prodia Widyahusada Tbk's value of $0.03 is 99.6% below this benchmark. Historically, PT Prodia Widyahusada Tbk's own Net Cash per Share has ranged from 3.75 to 9.23 over the past decade. While the company's 10-year median is 6.10 vs. the industry median of 7.96, PT Prodia Widyahusada Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Medical Diagnostics & Research company?
The median Net Cash per Share among Medical Diagnostics & Research companies is 7.96, based on 60 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Prodia Widyahusada Tbk's current Net Cash per Share of $0.03 is 99.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on PT Prodia Widyahusada Tbk and its competitors. For the Medical Diagnostics & Research industry, the median Net Cash per Share is 7.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Prodia Widyahusada Tbk's current Net Cash per Share is $0.03, which is 100% below median its own 10-year median of 6.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Prodia Widyahusada Tbk stock overvalued right now?
PT Prodia Widyahusada Tbk (PRWDF) has a current Net Cash per Share of $0.03. The current Net Cash per Share is $0.03, which is 100% below median its 10-year median of 6.10 and 99.6% below the Medical Diagnostics & Research industry median of 7.96. PT Prodia Widyahusada Tbk's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For PT Prodia Widyahusada Tbk (PRWDF), the current Net Cash per Share is $0.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Prodia Widyahusada Tbk provides health care testing services. The company provides analytic and diagnostic services for the medical professionals. It is engaged in health laboratories by conducting business activities such as setting up clinics, health laboratories, management of hospitals, and health checkup services. Its operating segments are Central: Jakarta; Sumatera: Sumatera, Kepulauan Riau; Greater Jakarta: Jakarta, Bogor, Depok, Tangerang, Bekasi, Lampung, Pangkal Pinang; West Java; Central Java; East Java, Bali, Nusa Tenggara; Kalimantan Sulampua: Kalimantan, Sulawesi, Ambon, Papua.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRWDF has been successfully added to your 
